Eighth International Congress on Drug Therapy in HIV Infection Glasgow, UK - 12-16 November 2006

Int Cong Drug Therapy HIV 2006 Nov 12-16;8:Abstract No. PL8.4

Paul Benn
Genitourinary Medicine and HIV, Mortimer Market Centre, London, UK

PURPOSE OF THE STUDY: The success of antiretroviral therapy and ongoing incident infection has led to many UK HIV treatment centres experiencing both significant increases in the size of their cohorts and changing needs of the HIV population, from the management of opportunistic infections to chronic disease. Furthermore, various factors such as commissioning pressures, national guidance and user involvement has impacted upon the way secondary HIV care is provided.

In response, services are required to reconsider existing models of care and in partnership with users to evolve acceptable pathways for the management of individuals living with HIV. I will describe our experience and approach to meeting the challenges of capacity issues while continuing to deliver an efficient and safe service. The re-evaluation of existing roles of health care providers within HIV services, including developing extended roles and non-medical prescribing, has been key. In addition, the successful implementation of several service innovations, including telephone consultations and e-mail communication, has afforded individuals more choice and have proven to be effective without compromising quality of care.

Plenary Session: Oral Papers

2006-11-12
PL8.4

Copyright © 2006 - Thomson ACUMED® All rights reserved. Thomson ACUMED® is an intelligent and innovative medical marketing and communications agency – a new division of The Gardiner-Caldwell Group Ltd, part of The Thomson Corporation, located in Tytherington, UK.

Reproduction of this abstract (other than one copy for personal reference) must be cleared through the authors.

This information is designed to support, not replace, the relationship that exists between you and your doctor. ©1980, 2006. AEGiS.